1. Home
  2. VS vs GOVX Comparison

VS vs GOVX Comparison

Compare VS & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Versus Systems Inc.

VS

Versus Systems Inc.

N/A

Current Price

$1.25

Market Cap

6.3M

Sector

Technology

ML Signal

N/A

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$2.77

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VS
GOVX
Founded
2013
2001
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VS
GOVX
Price
$1.25
$2.77
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$103.00
AVG Volume (30 Days)
16.8K
194.5K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,179,348.00
$3,353,560.00
Revenue This Year
$3,459.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2281.70
8.52
52 Week Low
$1.15
$2.61
52 Week High
$2.83
$53.73

Technical Indicators

Market Signals
Indicator
VS
GOVX
Relative Strength Index (RSI) 44.21 66.94
Support Level $1.22 $2.72
Resistance Level $1.29 $3.42
Average True Range (ATR) 0.05 0.39
MACD 0.01 0.08
Stochastic Oscillator 55.33 61.95

Price Performance

Historical Comparison
VS
GOVX

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: